Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.57 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | HTR1B | P28222 | 2/20 | 0.56 |
| ▸ | NSD2 | O96028 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | HTR1D | P28221 | 1/20 | 0.56 |
| ▸ | PPARD | Q03181 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.48 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.47 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4129206 | 0.99 | KDM4E (0.56) | KDM4EPLA2G4BALDH1A1HTR1BNSD2 | |
| SCHEMBL4591522 | 0.87 | KDM4E (0.52) | KDM4EPLA2G4BALDH1A1HTR1BNSD2 | |
| SCHEMBL25081992 | 0.86 | PLA2G4B (0.62) | PLA2G4BPPARDCYP4F2CYP4A11NR1H3 | |
| SCHEMBL30278809 | 0.86 | PLA2G4B (0.62) | PLA2G4BPPARDCYP4F2CYP4A11NR1H3 | |
| SCHEMBL4803459 | 0.86 | PLA2G4B (0.49) | KDM4EPLA2G4BALDH1A1NSD2SMN1; SMN2 | |
| SCHEMBL18294046 | 0.85 | KDM4E (0.50) | KDM4EALDH1A1HTR1BNSD2SMN1; SMN2 | |
| SCHEMBL25081990 | 0.84 | PLA2G4B (0.68) | KDM4EPLA2G4BALDH1A1PPARDGAA | |
| SCHEMBL30278807 | 0.84 | PLA2G4B (0.64) | PLA2G4BPPARDCYP4F2CYP4A11NR1H3 | |
| SCHEMBL25081989 | 0.84 | PLA2G4B (0.64) | PLA2G4BPPARDCYP4F2CYP4A11NR1H3 | |
| SCHEMBL30278815 | 0.84 | PLA2G4B (0.68) | KDM4EPLA2G4BALDH1A1PPARDGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090118263-A1 | Novel Adenine Compound | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2009-05-07 | — | — | US | disclosed |
| EP-1939202-A1 | NOVEL ADENINE COMPOUND | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2008-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090118263-A1 | Novel Adenine Compound | ADORA1, ADORA2A, ADORA3 | KDM4E 2809/4885PLA2G4B 2485/4885ALDH1A1 115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.